The impact of electrode size on transthoracic impedance and the dose-dependent efficacy of electrical cardioversion for elimination of atrial fibrillation persisting up to 48 hours in patients with ischemic heart disease was tested.
electrode           0.9999999994960831^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrode             

atrial fibrillation           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Atrial_fibrillation   

efficacy                      0.9999907050040497^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Efficacy              

impedance                     0.9997674254257537^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Electrical_impedance  

ischemic heart disease        0.9999997639192765^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Coronary_artery_disease

dose-dependent                0.8260282335000708^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Doseâ€“response_relationship

cardioversion                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cardioversion         

